Status:
TERMINATED
Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment in the Elderly
Lead Sponsor:
Nantes University Hospital
Conditions:
Oncology, Gerontology
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
The increasingly used oral anticancer treatments allow the patient to reduce treatment and social constraints to reduce hospitalization costs. The counterpart is a decrease in the monitoring of the co...
Eligibility Criteria
Inclusion
- Patient aged 70 and over
- Patient initiating an oral anticancer treatment (Chemotherapy, Targeted therapy, 2nd generation hormone therapy type Acetate abiraterone and Enzalutamide)
- Patient who received an onco-geriatric assessment
- Patient with informed consent signed
Exclusion
- Patient in a medical institution
- Patient under exclusive hormone therapy
- Patient already eligible for nurse support
- Patient not speaking French
- Patient under tutelage and guardianship or under safeguard of justice
- Patient already included in a research protocol
- Patient sharing his or her home with a person receiving nursing care at home more than once a week and for a period longer than 1 month after the patient's inclusion.
Key Trial Info
Start Date :
November 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2020
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT03300310
Start Date
November 15 2017
End Date
July 3 2020
Last Update
February 1 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
ICO Angers
Angers, France, 49000
2
CHD Vendée
La Roche-sur-Yon, France, 85000
3
CHU de Nantes
Nantes, France, 44000
4
Hôpital privé du Confluent
Nantes, France, 44200